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Abstract
Bone scintigraphy is widely considered as an important tech-
nique able to investigate various pathological conditions of 
the skeletal system. Many unexpected extraosseous uptakes 
have been reported in literature. We present here three cases 
of unexpected 99mTc-oxidronate (HDP) myocardial extraos-
seous uptakes in patients undergoing bone scan for staging 
purposes. In particular, we present the first reported case of 
a myocardial uptake in a patient with IgM-related amyloidosis. 
Subsequently, we perform a review of the existing literature 
about extraosseous uptakes. 
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uptake, amyloidosis
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Introduction
Bone scintigraphy is widely considered as an important tech-
nique able to investigate various pathological conditions of the 
skeletal system and its use is embedded in national and international 
guidelines. Many unexpected extraosseous uptakes have been re-
ported in literature: although several causes can be addressed, still 
the majority of cases do not recognize a clear pathological entity [1].
This phenomenon can be due to a huge variety of pathophysi-
ological mechanisms, such as an alteration in calcium metabolism, 
as it often happens in many systemic diseases, extracellular ﬂ uid ex-
pansion and enhanced regional vascularity and permeability [2, 3]; 
lung has been reported to be the most frequently site, followed by 
myocardium, chest wall. spleen, lymph nodes, kidney, stomach, 
retroperitoneum, adrenal gland, and pelvic cavity [4–9].
We present here three cases of unexpected 99mTc-oxidronate 
(HDP) uptakes in patients undergoing bone scan for staging pur-




A 75 year old man came to our observation in order to perform 
a bone scan for staging purposes. The patient has been diagnosed 
with prostate cancer two months before. Three hours after admi-
nistering 850 MBq 99mTc-HDP, we performed a total body scan. No 
clear metastatic lesions could be found, but there was an evidence 
of an unexpected myocardial uptake (Fig. 1). No possible underly-
ing causes could be detected, and the patient underwent a second 
bone scan two days later. The myocardial uptake was still present 
and an intense uptake involving the left upper extremity also could 
be detected (Fig. 2), not present on the ﬁ rst examination. The pa-
tient denied physical exercise the day before examination as well 
as receiving intravenous or intra-arterial drugs. Standard routine 
blood test were unremarkable, while D-dimer was not available. 
An extravenous administration was excluded, since the injection 
site was on the right arm. Likewise, a possible contamination 
was excluded. The possible cause of these extraosseous up-
takes remained unexplained.
Case 2
A 65 year-old woman came to our observation for staging pur-
poses after being diagnosed with breast cancer. Four hours after 
administering 780 MBq 99mTc-HDP, a total body bone scan was per-
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formed. The patient had no history of other diseases and she was on 
well-being at the observation. No symptoms were reported.
There was an evidence of small uptakes on the pelvis and the 
lumbar spine, probably related to arthrosis, and an extraosseous myo-
cardial uptake (Fig. 3). The patient had no history of cardiac diseases, 
but she was later investigated and diagnosed with amyloidosis.
Case 3
A 78 year-old woman came to our observation because of 
suspicion of a metastatic lesion located on the right knee. Three 
hours after administering 568 MBq 99mTc-HDP, the patient un-
derwent a total body bone scan, revealing an intense uptake on 
the right knee. A myocardial uptake was also evident (Fig. 4). The 
clinical history was investigated, and we found that the patient 
has been diagnosed with Waldenstrom disease two years before, 
and suffered from IgM-related amyloidosis. The patient was not 
on speciﬁ c therapy at the time of our observation. Right knee pain 
was the only symptom reported by the patient.
Discussion
Extraosseous uptakes of 99mTc-labelled phosphates have been 
reported in many papers, although they represent a relatively rare 
clinical entity (Table 1).
Figure 4. Bone scan (anterior and posterior view) in the patient 
described in case 3. There is an evidence of a myocardial uptake. The 
patient was later diagnosed with IgM-related amyloidosis
Figure 1. Bone scan (anterior and posterior view) in the patient 
described in case 1. There is an evidence of a myocardial uptake
Figure 2. The same patient of Figure 1 two days later: the myocardial 
uptake is still present, while there is a new large uptake on the left 
upper extremity
Figure 3. Bone scan (anterior and posterior view) in the patient 
described in case 2. There is an evidence of a myocardial uptake
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Different organs can present an abnormal uptake and this ﬁ nd-
ing is often accompanied by systemic diseases, although the under-
lying cause remains unknown in most cases. We could demonstrate 
a precise pathophysiological mechanism only in the patient of case 
no. 2, diagnosed with amyloidosis and in patient of case no. 3, who 
was diagnosed with Waldenstrom macroglobulinemia.
Although amyloidosis is a known complication of IgG gam-
mopathies, IgM-related amyloidosis represents an extremely rare 
entity, described in a few cases [10]. In particular, it was reported 
in only 2.2% of patients with IgM monoclonal gammopathies [11]. 
Patients affected by IgM-related amyloidosis usually present 
a peculiar pattern of organ involvement, with more frequent lymph 
node and lung involvement compared to patients with non-IgM 
amyloidosis [10].
An extraosseous uptake has been described before [12] in 
a patient affected by Waldenstrom macroglobulinemia, even if in 
this case only hepatic and spleen involvement was present, while 
our description is the ﬁ rst case of a myocardial uptake related to 
such a condition.
In our ﬁ rst case, no apparent explanation could be hypothesized 
for the uptake involving the left upper extremity. Phosphates up-
takes in soft tissues have also been reported and many causes have 
been described [13]; anyway, none of them were diagnosed in 
our patient and, moreover, there is not a clear explanation why 
this ﬁ nding was not present on the ﬁ rst body scan, performed only 
two days before. 
As previously mentioned, extravenous administration could not 
be a cause, since the site of injection was the right arm. For the 
Table 1. Conditions associated to extraosseous 99mTc-phosphates uptake during a bone scan and the most frequent localizations 
Alteration More frequent localizations
Neoplasia Prostate cancer Myocardium
Parathyroid adenoma and carcinoma Various organs




Melanoma Lung, stomach, kidney
Thyroid carcinoma Liver
Colon cancer Colon
Other tumors Various organs
Haematological disorders Lymphoma Spleen, other organs
Leukemia Spleen, other organs
Multiple myeloma Soft tissues, spleen, liver, other organs
Waldenstrom macroglobulinemia Lung, liver, spleen, other organs
Sickle cell disease Myocardium, other organs
Megaloblastic anemia Spleen
Thalassemia major Spleen
Metabolic diseases Nephrocalcinosis Myocardium
 Amyloidosis Myocardium, soft tissues
Hypercalcemia Myocardium
Alterations in calcium metabolism Soft tissues
Renal failure Lung, Myocardium, other organs
Calcinosis and calciﬁ cations Various organs
Hypersplenism Spleen
Iron overload Kidney
Vascular diseases Vasculitis Myocardium, lung, other organs
Atherosclerosis Myocardium
Infarction and ischemia Myocardium, spleen, brain
Inﬂ ammatory diseases Diverticulitis Colon
Other Physical exercise Soft tissues, muscles
Unknown origin Myocardium, soft tissues
Cold exposure Soft tissues
Aematomas Various localizations
Calcium injection Soft tissues
Arterial injection Soft tissues
Liver transplantation Soft tissues
85www.nmr.viamedica.pl
Federico Caobelli et al. Extraosseous myocardial uptake incidentally detected during bone scan
Review
same reason, contamination or intra-arterial injection, which was re-
ported to be another possible cause of soft tissue uptake [14], 
was excluded. The preparation of the radiopharmaceutical had 
no issues as well. 
Also physical exercise could be suspected: some cases have 
been reported in literature [15–20] but the pattern of uptake which 
is conﬁ ned to the left forearm makes this unlikely. Cold exposure 
was suspected as well, but could not be properly conﬁ rmed.
To our knowledge, no other reports can be found in literature, 
comparing two body scans and demonstrating the onset of an up-
take on an extremity in a so short time interval.
Other cases of myocardial uptake have been described in 
literature.
Al-Nahhas et al. described 19 myocardial uptakes (17 males, 
one female) and observed that most of the male patients with in-
creased myocardial uptake had prostatic carcinoma and were over 
80 years of age [21]. Wadhwa et al reported HDP uptake in cardiac 
amyloidosis in a background of tuberculosis, prostate cancer and 
coronary artery disease in an 86 year old patient. [22]. 
Chadrawar et al. presented another case of myocardial up-
take without a clear cause and reviewed the literature concerning 
this phenomenon [23]. Jones et al reported on prominent myocar-
dial uptake in 10 elderly men on HDP bone scan due to obscure 
benign etiology but presumably with atherosclerosis as contributing 
factor [24].
Other causes described in literature are amyloidosis [25–27], 
hypercalcemia [28, 29], metastases [30–32], vasculitis [33], nephro-
calcinosis [21]; anyway, in many cases no correlations with other 
pathologies can be demonstrated [34].
Soft tissues are other potential sites for extraosseous uptake 
and have been reported to be correlated to conditions like amyloido-
sis [35], alterations in calcium metabolism [36, 37], metastases [38] 
and multiple myeloma [39–41].
Extraosseous uptakes of 99mTc-labelled phosphates involv-
ing other organs are reported in patients with leukemia [41–44], 
parathyroid carcinoma [45], parathyroid adenoma [46], renal fail-
ure [38, 47, 48], lymphomas [49–51], multiple myeloma [52, 53], 
Waldenstrom macroglobulinemia [12, 54], hematological disor-
ders [55–60], tumors [61–69], calcinosis [70, 71] and vasculitis [72].
Finally, other papers report HDP uptakes in hematomas [4–9, 73], 
cold exposure [74], hypercalcemia [75], diverticulitis [76] and 
calcium injection [77].
Although calciﬁ cations in various organs could also be conse-
quent to multiple small infarcts of extremely small size [78–80], deﬁ -
nite pathologic ﬁ ndings which could demonstrate the presence of 
ischemia can be hardly found in the cases reported in literature [81].
There is an evidence that calcium phosphate molar ratio, 
crystalline surface area, and presence of other metallic ions are 
factors that determine the reactivity of diphosphonates to a calcium 
deposition [75, 82]; as an example, high concentrations of iron in 
soft tissues produce extraskeletal Tc-99m MDP uptake [60, 83].
The most probable mechanism is an impairment of calcium 
metabolism, as it can be often observed in systemic diseases and 
in some paraneoplastic syndromes; normally, pure and amor-
phous calcium phosphate accumulations with a low molar ratio 
and a large surface area can be found in sites of 99mTc-labelled 
phosphates, causing an avid diphosphonate adsorption similar to 
that of mature hydroxyapatite [71].
Conclusion
Extraosseous uptake of 99mTc-labelled phosphates is a rela-
tively rare ﬁ nding, which is however increasing in clinical reports.
Large studies investigating the precise pathophysiologic 
mechanisms related to this phenomenon would be desirable, even 
if the huge variability of possible conditions limits this possibility.
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